Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
This piece explains glide path withdrawal strategies for index funds, focusing on steady income while managing sequence of returns risk.
25,774 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Bitcoin trades near the mid-$60,000s after testing $70,000 earlier this week. Analysts say long-term holder activity ...
Revolut has begun launching its UK bank after a regulator lifted license restrictions. The phased migration will roll...
Jim Cramer’s take on Power Solutions International’s sharp drop spotlights a potential entry point for data center-re...
U.S. drone output is under scrutiny as manufacturers push for scale. Red Cat and AeroVironment highlight a market shi...
Egg prices have fallen sharply as the worst of the avian flu outbreak eases, but traders warn that fresh outbreaks co...
Fewer Gen Z adults are forming romantic relationships, a trend linked to softer social skills and new onboarding chal...
A major March storm grounded more than 1,800 flights across the United States, snarling spring break travel and forci...
When housing activity ebbs, flooring companies face a turning point. This article explores how a leading flooring com...
General Mills sits near $39 after a soft quarter, boosting the dividend to about 6.3%. Retirees eyeing general mills’...
BNB Chain unveils the BNBAgent SDK, the first live implementation of ERC-8183, enabling trustless, autonomous AI work...
Oracle has reframed the AI shift as a disruption to traditional SaaS growth. This article explains why that view matt...